Inhalation Sciences Sweden AB (publ)

NGM:ISAB Stock Report

Market Cap: SEK 65.8m

Inhalation Sciences Sweden Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Manoush Masarrat

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3.9yrs

Recent management updates

Recent updates

We're Not Counting On Inhalation Sciences Sweden (NGM:ISAB) To Sustain Its Statutory Profitability

Dec 29
We're Not Counting On Inhalation Sciences Sweden (NGM:ISAB) To Sustain Its Statutory Profitability

CEO

Manoush Masarrat (46 yo)

4.6yrs

Tenure

Mr. Manoush Masarrat has been Chief Executive Officer at Inhalation Sciences Sweden AB (publ) since September 16 2019. Mr. Masarrat had served as Director of Inhalation Sciences Sweden AB (publ) since Dece...

Board Members

NamePositionTenureCompensationOwnership
Per Gerde
Chief Scientific Officer & Directorno datano data5.08%
SEK 3.3m
Per Wollmer
Member of Advisory Boardno datano datano data
Daniel Spasic
Chairman of the Board3.9yrsno datano data
Jan Hellqvist
Director1.6yrsno datano data
Sonja Gerde
Director5.9yrsno datano data
Gary Pitcairn
Member of Advisory Boardno datano datano data
Martin Wehling
Member of Advisory Boardno datano datano data
Magnus Svartengren
Member of Advisory Boardno datano datano data
Carsten Ehrhardt
Member of Advisory Boardno datano datano data

3.9yrs

Average Tenure

58yo

Average Age

Experienced Board: ISAB's board of directors are considered experienced (3.9 years average tenure).